CN101991681A - Traditional Chinese medicine for treating benign prostatic hyperplasia - Google Patents
Traditional Chinese medicine for treating benign prostatic hyperplasia Download PDFInfo
- Publication number
- CN101991681A CN101991681A CN2010105429299A CN201010542929A CN101991681A CN 101991681 A CN101991681 A CN 101991681A CN 2010105429299 A CN2010105429299 A CN 2010105429299A CN 201010542929 A CN201010542929 A CN 201010542929A CN 101991681 A CN101991681 A CN 101991681A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- prostatic hyperplasia
- radix
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating benign prostatic hyperplasia, belonging to the field of the traditional Chinese medicines for treating urinary system diseases and aiming at achieving the purposes of good effect and quick response. The traditional Chinese medicine is prepared from the raw materials of baical skullcap root, Chinese angelica, lucid ganoderma, red-rooted salvia root, pseudo-ginseng, pink herb, cape Jasmine fruit and the like, and has the effects of strengthening and consolidating the body resistance, tonifying qi and nourishing the blood, promoting blood circulation and removing blood stasis, inducing diuresis for removing edema, as well as excreting dampness and treating stranguria, and has the advantages of obvious effect, definite medicinal effect and quicker response.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment diseases of urinary system.
Background technology
The present Chinese medicine aspect that is used for the treatment of male prostatic hyperplasia, the deficiency that has two aspects: the one, effect is obvious inadequately, the 2nd, it is slower to take effect, so that large quantities of prostatic hyperplasia patients are because of can not get the treatment of active drug for a long time, frequent frequent micturition, urgent micturition, dysurea, unable, the urine retention of urine, urinary incontinence, protracted course of disease, symptoms such as very misery, and Chang Bingfa urine retention, hematuria, perineal position pain.Patient and family members thereof are very dissatisfied.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of prostatic hyperplasia, it can solve, and this type of Chinese medicine effect was obvious inadequately in the past, and the slower problem that takes effect is effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of prostatic hyperplasia adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Radix Scutellariae 5-15 part Radix Angelicae Sinensis 6-18 part Ganoderma 6-18 part
Radix Salviae Miltiorrhizae 6-18 part Radix Notoginseng 3-9 part Herba Dianthi 5-15 part
Fructus Gardeniae 5-15 part
The Chinese medicine of this treatment prostatic hyperplasia is made by following method:
(1) by above-mentioned weight ratio, Ganoderma is extracted ganoderan with decoction and alcohol sedimentation technique, technological process is as follows: Ganoderma is broken into graininess, cross 40 mesh sieves →, concentrate → mixed, leave standstill 10-12 hour, centrifugal → as to add 75% ethanol with 95% ethanol of 3 times of volumes with 1: 20 hot water (95 ℃) lixiviate → lixiviating solution decompression, precipitate polysaccharide → dry the ganoderan extract fine powder;
(2) by above-mentioned weight ratio, Radix Scutellariae, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Herba Dianthi, Fructus Gardeniae are extracted through conventional water extraction process, make extract extractum fine powder;
(3) by above-mentioned weight ratio, Radix Notoginseng is ground into fine powder, mixes, stir, make Chinese medicine granules, capsule, tablet with above-mentioned (1), (2) two kinds of extract fine powders.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma, Radix Angelicae Sinensis the body resistance strengthening and constitution consolidating in the side, benefiting QI and nourishing blood, enhancing human body immunity power; Radix Salviae Miltiorrhizae, Radix Notoginseng nourshing blood and promoting blood circulation, blood-activating analgetic; Be aided with the Radix Scutellariae heat clearing and damp drying, eliminating fire and detoxication; Herba Dianthi, Fructus Gardeniae inducing diuresis for treating stranguria syndrome, Herba Dianthi clearing heat and freeing strangury removing heat from blood, the diuresis of Fructus Gardeniae heat clearing and blood cooling, the two 5 be a usefulness mutually, effect that heat clearing and blood cooling is treating stranguria enhancing is used for the treatment of urinary obstruction, the odynuria effect is distinguished.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, inducing diuresis to remove edema, the merit that eliminating dampness by diuresis is treating stranguria, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Radix Scutellariae 60 gram Radix Angelicae Sinensis 70 kairine sesames 70 grams
Radix Salviae Miltiorrhizae 70 gram Radix Notoginseng 30 gram Herba Dianthis 60 grams
Fructus Gardeniae 60 grams
Weight is extracted Ganoderma with decoction and alcohol sedimentation technique in accordance with regulations; With conventional water extraction process Radix Scutellariae, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Herba Dianthi, Fructus Gardeniae are extracted, make extract fine powder 78 grams altogether, Radix Notoginseng is ground into fine powder, mix with said extracted thing fine powder, stir, make fine particle, the capsule of packing into No. 0, make 385 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Radix Scutellariae 100 gram Radix Angelicae Sinensis 120 kairine sesames 120 grams
Radix Salviae Miltiorrhizae 120 gram Radix Notoginseng 50 gram Herba Dianthis 100 grams
Fructus Gardeniae 100 grams
By above-mentioned same method, make 650 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Radix Scutellariae 150 gram Radix Angelicae Sinensis 180 kairine sesames 180 grams
Radix Salviae Miltiorrhizae 180 gram Radix Notoginseng 80 gram Herba Dianthis 150 grams
Fructus Gardeniae 150 grams
By above-mentioned same method, make 992 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
7 parts of 7 portions of Ganodermas of 6 parts of Radix Angelicae Sinensis of Radix Scutellariae
6 parts of 3 portions of Herba Dianthis of 7 portions of Radix Notoginseng of Radix Salviae Miltiorrhizae
6 parts of Fructus Gardeniaes
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
15 parts of 15 portions of Ganodermas of 12 parts of Radix Angelicae Sinensis of Radix Scutellariae
12 parts of 7 portions of Herba Dianthis of 15 portions of Radix Notoginseng of Radix Salviae Miltiorrhizae
12 parts of Fructus Gardeniaes
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is example with the prostatic hyperplasia, through 7 routine clinical observations.Selecting the tcm diagnosis prostatic hyperplasia is standard: male's limb is soft weak, physical weakness, and it is not smooth to urinate---and frequent micturition, urgent micturition, dysurea, urine are unable, urine retention, urine are hesitated, urine retention; Clinical rectal touch can contact the prostate of increase.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, be the male all, there is not other serious disease, the age is 49 years old-81 years old, 71.2 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, on one's body energetically; Frequent micturition, urgent micturition, dysurea are obviously alleviated; Urine retention, urine are hesitated, urine retention obviously alleviates; The visible prostate of rectal touch increases (expansion of prostate both sides page or leaf) and alleviates.
2, effective: body constitution strengthens, on one's body energetically; Frequent micturition, urgent micturition, dysurea are alleviated to some extent; Urine is hesitated, urine retention alleviates to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 30 days, take 3 months after, symptom is obviously improved.7 philtrums of clinical experiment, produce effects 4 people, effective 2 people, invalid 1 people, total effective rate 85.7%.
Claims (1)
1. Chinese medicine for the treatment of prostatic hyperplasia, it is characterized in that: it is to make with the component of following weight ratio: Radix Scutellariae 5-15 part, Radix Angelicae Sinensis 6-18 part, Ganoderma 6-18 part, Radix Salviae Miltiorrhizae 6-18 part, Radix Notoginseng 3-9 part, Herba Dianthi 5-15 part, Fructus Gardeniae 5-15 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105429299A CN101991681A (en) | 2010-11-11 | 2010-11-11 | Traditional Chinese medicine for treating benign prostatic hyperplasia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105429299A CN101991681A (en) | 2010-11-11 | 2010-11-11 | Traditional Chinese medicine for treating benign prostatic hyperplasia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101991681A true CN101991681A (en) | 2011-03-30 |
Family
ID=43782758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105429299A Pending CN101991681A (en) | 2010-11-11 | 2010-11-11 | Traditional Chinese medicine for treating benign prostatic hyperplasia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101991681A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112826881A (en) * | 2021-01-29 | 2021-05-25 | 广东德鑫制药有限公司 | A pharmaceutical composition for treating prostatic hyperplasia, and its preparation method |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1478538A (en) * | 2002-08-26 | 2004-03-03 | 上海中耀生物科技有限公司 | Chinese medicinal composition for treating prostate cancer, its preparation method and its application in the preparation of medicine for treating prostate cancer |
| CN101843699A (en) * | 2009-10-16 | 2010-09-29 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating benign prostatic hyperplasiabrain |
| CN101843804A (en) * | 2009-10-22 | 2010-09-29 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating benign prostatic hyperplasiabrain |
-
2010
- 2010-11-11 CN CN2010105429299A patent/CN101991681A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1478538A (en) * | 2002-08-26 | 2004-03-03 | 上海中耀生物科技有限公司 | Chinese medicinal composition for treating prostate cancer, its preparation method and its application in the preparation of medicine for treating prostate cancer |
| CN101843699A (en) * | 2009-10-16 | 2010-09-29 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating benign prostatic hyperplasiabrain |
| CN101843804A (en) * | 2009-10-22 | 2010-09-29 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating benign prostatic hyperplasiabrain |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112826881A (en) * | 2021-01-29 | 2021-05-25 | 广东德鑫制药有限公司 | A pharmaceutical composition for treating prostatic hyperplasia, and its preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101843787B (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
| CN102172374A (en) | Traditional Chinese medicine for treating hyperplasia of prostate | |
| CN102389530A (en) | Traditional Chinese medicine for curing benign prostatic hyperplasia | |
| CN102114172A (en) | Traditional Chinese medicine for treating hyperplasia of prostate | |
| CN102068594A (en) | Chinese medicament for treating chronic prostatitis | |
| CN101972349A (en) | Traditional Chinese medicine for treating benign prostatic hyperplasia | |
| CN102068529A (en) | Traditional Chinese medicine for treatment of prostatic hyperplasia | |
| CN102327350A (en) | Traditional Chinese medicine for treating prostatic hyperplasia | |
| CN102389522A (en) | Traditional Chinese medicine for treating prostatic hyperplasia | |
| CN102091130A (en) | Traditional Chinese medicine for treating liver cirrhosis | |
| CN102172369A (en) | Chinese medicine for treating hepatocirrhosis | |
| CN102389477A (en) | Traditional Chinese medicine for treating benign prostatic hyperplasia | |
| CN102380023A (en) | Chinese medicament for treating benign prostatic hyperplasia | |
| CN102389523A (en) | Traditional Chinese medicine for treating benign prostatic hyperplasia | |
| CN102389525A (en) | Traditional Chinese medicine for curing benign prostatic hyperplasia | |
| CN101991681A (en) | Traditional Chinese medicine for treating benign prostatic hyperplasia | |
| CN101972426A (en) | Traditional Chinese medicine for treating chronic prostatitis | |
| CN102138992A (en) | Traditional Chinese medicine for treating benign prostatic hyperplasia | |
| CN102091157A (en) | Traditional Chinese medicine for treating hyperplasia of prostate | |
| CN102631459A (en) | Traditional Chinese medicine for treating chronic prostatitis | |
| CN102114100A (en) | Traditional Chinese medicine for treating prostatic hypertrophy | |
| CN102068569A (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN102389531A (en) | Traditional Chinese medicine for curing chronic prostatitis | |
| CN101961407A (en) | Traditional Chinese medicine for treating prostatic hyperplasia | |
| CN101961416A (en) | Traditional Chinese medicine for treating chronic prostatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110330 |